BioRender has 6 close competitors: Adarx, Chronosphere, Drift.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
BioRenderChronosphereDriftEsriGhostGuestyBioRender is a scientific figure and illustration software platform enabling researchers to create professional science figures using AI-powered tools, providing over 50,000 scientifically accurate icons and templates used by millions of scientists globally.
BioRender competes with 6 companies here: Adarx, Chronosphere, Drift, Esri, Ghost, Guesty.
BioRender was last valued at $900M (post-money, Dec 2025). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The closest scientific visualization software peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. BioRender is a private company; its shares do not trade on a public exchange.
The last valuation is $900M (post-money, Dec 2025).
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
